Russia mandates local clinical trials for new imported veterinary drugs

Russia's cabinet backed a bill requiring clinical trials of unregistered imported veterinary drugs to be conducted domestically, a protectionist measure favoring local producers. This continues Russia's import-substitution drive in the veterinary sector, potentially raising entry barriers for foreign suppliers. The bill's passage through parliament remains pending, and its impact on trade flows is uncertain.